Close Menu

Europe

A genetic analysis has uncovered what appears to be Converso ancestry among a large cohort of Latin American individuals, Forbes reports.

Search for Risk

A University College London team aims to examine genetic and other factors influencing eating disorder risk, according to the Guardian.

A new analysis found kidney disease-related pathogenic or likely pathogenic variants in exomes for roughly 9 percent of individuals with chronic kidney disease.

Doing OK

The Guardian reports that biotech in the UK has been reaping investments despite the upcoming Brexit.

In Genome Biology this week: catalog of curated human genes and transcripts; potential biomarkers for aging; and more.

The funds will provide financial support to the genome center's data and information technology unit beginning next year.

Researchers tested the combined PGS and PGD assay in a pilot study and now aim to validate it on larger numbers of disorders and compare it to conventional testing.

QuantuMDx and Molbio Diagnostics said this week they have signed a memorandum of understanding to work jointly in infectious disease diagnostics.

A GWAS meta-analysis involving 10,074 PCOS cases revealed three new and 11 known risk loci, along with a relatively consistent genetic architecture among cases.

In Science this week: single-cell tools named Breakthrough of the Year winner, differences in gut microbiome composition and function in people with bowel disease, and more.

Pages

The US has sent its formal notice of withdrawal from the World Health Organization, according to the Wall Street Journal.

Science reports that a draft spending bill would increase the US National Institutes of Health budget by 13 percent.

The Harvard Crimson reports that Harvard and MIT are suing the Department of Homeland Security and ICE over the new international student visa policy.

In Nucleic Acids Research this week: algorithm to determine molecular sequence types and other microbial features, computational method to uncover R-loop structures, and more.